Vanguard Group »

Aerovate Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.8M 1.1M 1.66
2024-03-31 $20M 672k 29.57
2023-12-31 $14M 627k 22.63
2023-09-30 $8.1M 599k 13.57
2023-06-30 $9.0M 524k 17.15
2023-03-31 $10M 513k 20.17
2022-12-31 $15M 500k 29.30
2022-06-30 $6.9M 442k 15.63
2022-03-31 $8.8M 480k 18.33
2021-09-30 $16M 781k 20.98